Regeneron Pharmaceuticals Inc
NASDAQ:REGN

Watchlist Manager
Regeneron Pharmaceuticals Inc Logo
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Watchlist
Price: 783.71 USD -0.19% Market Closed
Market Cap: 82.4B USD

Wall Street
Price Targets

REGN Price Targets Summary
Regeneron Pharmaceuticals Inc

Wall Street analysts forecast REGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for REGN is 808.25 USD with a low forecast of 633.27 USD and a high forecast of 1 109.85 USD.

Lowest
Price Target
633.27 USD
19% Downside
Average
Price Target
808.25 USD
3% Upside
Highest
Price Target
1 109.85 USD
42% Upside
Regeneron Pharmaceuticals Inc Competitors:
Price Targets
ATRA
Atara Biotherapeutics Inc
14% Upside
TECX
AVROBIO Inc
274% Upside
BBIO
BridgeBio Pharma Inc
12% Upside
TGTX
TG Therapeutics Inc
45% Upside
QTTB
Homology Medicines Inc
261% Upside
600201
Jinyu Bio-Technology Co Ltd
42% Downside
VCEL
Vericel Corp
49% Upside
OXB
Oxford BioMedica PLC
24% Upside

Revenue
Forecast

Revenue Estimate
Regeneron Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's revenue is 31%. The projected CAGR for the next 4 years is 6%.

31%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Regeneron Pharmaceuticals Inc

The compound annual growth rate of Regeneron Pharmaceuticals Inc's operating income for the next 4 years is 13%.

N/A
Past Growth
13%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

Net Income Estimate
Regeneron Pharmaceuticals Inc

The compound annual growth rate of Regeneron Pharmaceuticals Inc's net income for the next 4 years is 8%.

N/A
Past Growth
8%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is REGN's stock price target?
Price Target
808.25 USD

According to Wall Street analysts, the average 1-year price target for REGN is 808.25 USD with a low forecast of 633.27 USD and a high forecast of 1 109.85 USD.

What is Regeneron Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's revenue is 31%. The projected CAGR for the next 4 years is 6%.

What is Regeneron Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
13%

The compound annual growth rate of Regeneron Pharmaceuticals Inc's operating income for the next 4 years is 13%.

What is Regeneron Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
8%

The compound annual growth rate of Regeneron Pharmaceuticals Inc's net income for the next 4 years is 8%.

Back to Top